UNC Lineberger Comprehensive Cancer Center: Neoplasms trials

The registry lists 49 Neoplasms studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 16 are open to participants now and 10 have results posted.

Phase 1 11Phase 2 6No phase 34(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Feasibility Pilot of AYA-PARTNERNot yet recruitingNCT07829146Not applicable
• Improving Affordability in Cancer Care Through Economic Screening and Support (I-ACCESS)Not yet recruitingNCT07664436Not applicable
• Local Radiofrequency Ablation Plus External Beam Radiation for the Treatment of Painful Thoracic and Lumbar Spine TumorsRecruitingNCT07479199
• Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation OncologyRecruitingNCT07463833Not applicable
• Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer SurvivorsRecruitingNCT06848491Not applicable
• Rehabilitation Outcomes StudyRecruitingNCT06674889Not applicable
• Effectiveness of Central Oncology Navigation and the Use of an ORNRecruitingNCT06618274Not applicable
• UNC Metastatic Cancer Radiation Therapy RegistryRecruitingNCT06306924
• Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCCRecruitingNCT06096038Phase 1
• Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RTNot yet recruitingNCT05937659
• Young Adult Infusion Space Experience Satisfaction SurveyRecruitingNCT05720546
• UNC Pleural Fluid RegistryRecruitingNCT05620329
• Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple MyelomaRecruitingNCT05145400Phase 2
• UNC Childhood, Adolescent, and Young Adult Cancer CohortRecruitingNCT05096923
• Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsRecruitingNCT03454035Phase 1
• Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruitingNCT01137643
• Physical Activity and Healthy Eating Among Young Adult Cancer SurvivorsCompletedNCT05887401Not applicableResults posted
• Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive InterventionsCompletedNCT05751993Not applicableResults posted
• Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®CompletedNCT05011890Not applicableResults posted
• Addressing Cancer-Related Financial Toxicity in North Carolina Oncology Care SettingsCompletedNCT04931251Not applicableResults posted
• An Evaluation of the Families Addressing Cancer Together (FACT) InterventionCompletedNCT04342871Not applicableResults posted
• P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCCCompletedNCT03077243Phase 2Results posted
• Administration of T Lymphocytes for Prevention of Relapse of LymphomasActive, not recruitingNCT02663297Phase 1Results posted
• De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up StudyCompletedNCT02281955Phase 2Results posted
• De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCompletedNCT01530997Phase 2Results posted
• Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver MetastasesCompletedNCT01528878Not applicableResults posted
• Keep Social Randomized Controlled Trial for Young Adults With CancerActive, not recruitingNCT07788339Not applicable
• Social Media Posts About Cancer: Five TimepointsCompletedNCT07588607Not applicable
• Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T CellsWithdrawnNCT07071909Phase 1/2
• Adaptation of a Values Assessment ToolCompletedNCT07068477Not applicable
• Expanding the Support of Family Caregivers of Diverse Patients With Cancer and DiabetesActive, not recruitingNCT07061652Not applicable
• Medically Tailored Meals for KidsActive, not recruitingNCT06814795Not applicable
• Digital Art Therapy for Young Cancer SurvivorsTerminatedNCT06789666Not applicable
• Mobile Weight Loss Intervention for Adolescent and Young Adult Cancer SurvivorsCompletedNCT06171945Not applicable
• The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer TreatmentCompletedNCT06096623
• Measuring Changes in Body Composition and Physical Function in Patients With Childhood CancersCompletedNCT05823740Not applicable
• Immuno-Oncology Database and BioregistryCompletedNCT04656873
• The STEPP Study: Sensors To Evaluate Physical PerformanceCompletedNCT03952767Not applicable
• Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer PatientsCompletedNCT03951090Not applicable
• Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCLActive, not recruitingNCT03602157Phase 1
• Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback StrategiesCompletedNCT03569605Not applicable
• Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHLActive, not recruitingNCT02690545Phase 1/2
• Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
• Study of the P16 Gene as a Predictor of Myelosuppression in Breast Cancer PatientsCompletedNCT01305954
• Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue SarcomaTerminatedNCT01204450Phase 1
• Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid TumorsCompletedNCT00573690Phase 1
• Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00520000Phase 1
• Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT00320073Phase 1
• Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid TumorsCompletedNCT00307255Phase 1